I'm sorry , CT, I must have missed that. Where are the trials being conducted? Was there a PR announcing that the IND had been submitted? Approved? Or is this all happening overseas?
I think the gap from .90 just got filled, unfortunately it looked like it would. Holding .95 is important , I think we'll do it and this is a test like the test of breakouts @.60 & .85 were. Cortex is still in biotech pergatory, for now-but I think we have unreally favorable risk reward right here. None down 2 or 3 points in upside....